Trial Profile
A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Effect of D797 on Pharmacokinetics of D324 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Jun 2018
Price :
$35
*
At a glance
- Drugs Donepezil (Primary) ; Memantine (Primary)
- Indications Alzheimer's disease; Cognition disorders; Dementia; Down syndrome; Lewy body disease; Vascular dementia
- Focus Pharmacokinetics
- Acronyms CKD-355 DDI P1
- Sponsors Chong Kun Dang
- 29 Jun 2018 New trial record